Leveraging Rapid Multiplex Testing During the Height of Respiratory Season

Life Sciences, Medical Device, Healthcare, Medical Device Diagnostics, Laboratory Technology,
  • Monday, December 12, 2022

A return to pre-pandemic activities, coupled with a reduction in the population’s collective immunity, has led to global surges in respiratory pathogens, including RSV and influenza. When several respiratory pathogens are circulating at once, rapid multiplex diagnostic testing can help healthcare providers (HCPs) more efficiently manage their patients. These tests increase opportunities for the detection of respiratory pathogens and can help avoid misdiagnosis due to overlapping clinical symptoms. And by eliminating diagnostic uncertainty, they can help HCPs decide when to start or stop antimicrobial therapy with more confidence.

With alarming increases in antimicrobial resistance rates, eliminating unnecessary antibiotic use has become more important than ever. Multiplex testing can be leveraged as the bridge between diagnostic stewardship and antimicrobial stewardship, advocating for the right test, in the right patient, at the right time.

Join featured speaker, Dr. Shah, for this interesting webinar as he walks through the benefits of multiplex diagnostic testing. He’ll focus on the unique benefits offered by the QIAstat-Dx, a multiplex diagnostic real-time PCR-based system, including real-time epidemiology tracking.

Register now to learn more about leveraging rapid multiplex testing during the height of the respiratory season.


Anooj Shah, QIAGEN

Anooj Shah, PharmD, MBA, BCIDP, Medical Science Liaison, Infectious Diseases, QIAGEN

Anooj Shah is a QIAGEN Medical Science Liaison with expertise in infectious diseases and antimicrobial stewardship. After receiving his PharmD/MBA from Concordia University Wisconsin, School of Pharmacy, he completed two years of post-graduate residency training at Northwestern Medicine in Chicago, USA, specializing in infectious diseases. He practiced as an infectious diseases and antimicrobial stewardship pharmacist at Northwest Community Hospital for two years prior to joining QIAGEN.

Message Presenter

Who Should Attend?

  • Laboratorians
  • Lab Managers
  • Key Purchasing Drivers (CFO)
  • Healthcare Providers (infectious diseases specialists, pulmonologists, other)
  • Clinical Laboratorians
  • Diagnostic Laboratorians
  • Antimicrobial Stewardship Board Members
  • ICU Staff
  • ER Staff

What You Will Learn

  • Benefits of multiplex respiratory panels tests for patient management, especially in the context of antimicrobial stewardship initiatives
  • Understand clinical situations in which a lowplex test is appropriate and when the additional diagnostic coverage provided by a multiplex test is justified
  • The risks of antimicrobial resistance and the implications of a robust antimicrobial stewardship program
  • How real-time epidemiology tracking can support enhanced surveillance and faster responses to outbreaks

Xtalks Partner


QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Further information can be found at http://www.qiagen.com.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account